206 related articles for article (PubMed ID: 19364692)
1. Hypercalcemia of malignancy with simultaneous elevation in serum parathyroid hormone--related peptide and 1,25-dihydroxyvitamin D in a patient with metastatic renal cell carcinoma.
Shivnani SB; Shelton JM; Richardson JA; Maalouf NM
Endocr Pract; 2009 Apr; 15(3):234-9. PubMed ID: 19364692
[TBL] [Abstract][Full Text] [Related]
2. Hypercalcemia in patients with metastatic renal cell carcinoma: effect of nephrectomy and metabolic evaluation.
Walther MM; Patel B; Choyke PL; Lubensky IA; Vocke CD; Harris C; Venzon D; Burtis WJ; Linehan WM
J Urol; 1997 Sep; 158(3 Pt 1):733-9. PubMed ID: 9258070
[TBL] [Abstract][Full Text] [Related]
3. Circulating 1,25-dihydroxyvitamin D concentrations in patients with renal cell carcinoma-associated hypercalcemia are rarely suppressed.
Yamamoto I; Kitamura N; Aoki J; Kawamura J; Dokoh S; Morita R; Torizuka K
J Clin Endocrinol Metab; 1987 Jan; 64(1):175-9. PubMed ID: 3782432
[TBL] [Abstract][Full Text] [Related]
4. Hypercalcemia secondary to leprosy.
Couri CE; Foss NT; Dos Santos CS; de Paula FJ
Am J Med Sci; 2004 Dec; 328(6):357-9. PubMed ID: 15599334
[TBL] [Abstract][Full Text] [Related]
5. 1,25-dihydroxyvitamin D and PTHrP mediated malignant hypercalcemia in a seminoma.
Rodríguez-Gutiérrez R; Zapata-Rivera MA; Quintanilla-Flores DL; Camara-Lemarroy CR; Lavalle-Gonzalez FJ; González-González JG; Villarreal-Pérez JZ
BMC Endocr Disord; 2014 Apr; 14():32. PubMed ID: 24721620
[TBL] [Abstract][Full Text] [Related]
6. Hypercalcemia in a patient with renal cell carcinoma producing parathyroid hormone-related protein and interleukin-6.
Ueno M; Ban S; Nakanoma T; Tsukamoto T; Nonaka S; Hirata R; Iida M; Deguchi N
Int J Urol; 2000 Jun; 7(6):239-42. PubMed ID: 10843457
[TBL] [Abstract][Full Text] [Related]
7. Humoral hypercalcemia of malignancy in a patient with large cell carcinoma of the lung: report of case and review of literature.
Makdissi A; Zimmerman RS
Endocr Pract; 2007; 13(4):389-95. PubMed ID: 17669716
[TBL] [Abstract][Full Text] [Related]
8. The coexistence of renal cell carcinoma and diffuse large B-cell lymphoma with hypercalcemic crisis as the initial presentation.
Yilmaz H; Namuslu M; Bilgic MA; Bavbek N; Akcay A
Endocr Regul; 2014 Jul; 48(3):113-9. PubMed ID: 25110209
[TBL] [Abstract][Full Text] [Related]
9. Hypercalcemia and cosecretion of interleukin-6 and parathyroid hormone related peptide by a human renal cell carcinoma implanted into nude mice.
Weissglas M; Schamhart D; Löwik C; Papapoulos S; Vos P; Kurth KH
J Urol; 1995 Mar; 153(3 Pt 1):854-7. PubMed ID: 7861550
[TBL] [Abstract][Full Text] [Related]
10. Parathyroid hormone-related protein (PTHrP) does not regulate 1,25-dihydroxyvitamin D serum levels in hypercalcemia of malignancy.
Schilling T; Pecherstorfer M; Blind E; Leidig G; Ziegler R; Raue F
J Clin Endocrinol Metab; 1993 Mar; 76(3):801-3. PubMed ID: 8445039
[TBL] [Abstract][Full Text] [Related]
11. Approach to diagnosis and treatment of hypercalcemia in a patient with malignancy.
Reagan P; Pani A; Rosner MH
Am J Kidney Dis; 2014 Jan; 63(1):141-7. PubMed ID: 24021907
[TBL] [Abstract][Full Text] [Related]
12. Humoral Hypercalcemia in Uterine Cancers: A Case Report and Literature Review.
Motilal Nehru V; Garcia G; Ding J; Kong F; Dai Q
Am J Case Rep; 2017 Jan; 18():22-25. PubMed ID: 28057913
[TBL] [Abstract][Full Text] [Related]
13. Differential diagnosis of hypercalcemia in renal malignancy.
Klatte T; Said JW; Belldegrun AS; Pantuck AJ
Urology; 2007 Jul; 70(1):179.e7-8. PubMed ID: 17656242
[TBL] [Abstract][Full Text] [Related]
14. Parathyroid hormone-related protein and serum calcium in patients with renal cell carcinoma.
Papworth K; Grankvist K; Ljungberg B; Rasmuson T
Tumour Biol; 2005; 26(4):201-6. PubMed ID: 16006777
[TBL] [Abstract][Full Text] [Related]
15. Hypercalcemia and acute renal failure caused by production of parathyroid hormone-related protein from renal cell carcinoma.
Ueno M; Ohigashi T; Nakashima J; Nonaka S; Deguchi N; Murai M
Scand J Urol Nephrol; 2002; 36(2):149-51. PubMed ID: 12028689
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine Carcinoma as a Cause of Humoral Hypercalcemia of Malignancy: A Case of a Patient With Elevated Parathyroid Hormone-Related Protein.
Christensen BR; Rendo MJ; Beeler BW; Huddleston BJ; Fenderson JL
Cureus; 2022 Mar; 14(3):e23398. PubMed ID: 35481321
[TBL] [Abstract][Full Text] [Related]
17. Contribution of parathyroid hormone-related peptide to the evaluation of hypercalcemia.
Audran M; Minebois-Villégas A; Lortholary A; Legrand E; Pascaretti C; Giraud P; Subra JF; Boasson M; Jallet P
Rev Rhum Engl Ed; 1995 Mar; 62(3):189-96. PubMed ID: 7788336
[TBL] [Abstract][Full Text] [Related]
18. Hypercalcemia induced with the plasma levels of parathyroid hormone-related peptide in multiple myeloma.
Shionoiri A; Horiuchi T; Onouchi T; Tsutsumi H; Ohta M; Hosoi T; Ito H; Orimo H
Intern Med; 2000 Oct; 39(10):810-3. PubMed ID: 11030205
[TBL] [Abstract][Full Text] [Related]
19. A patient with severe hypercalcemia in multiple organ dysfunction syndrome: role of elevated circulating 1alpha,25(OH)2 vitamin D levels.
Kazama JJ; Yamamoto T; Oya H; Yamamoto S; Sato Y; Sakurada J; Honda T; Endoh H; Narita I
J Bone Miner Res; 2010 Jun; 25(6):1455-9. PubMed ID: 20200933
[TBL] [Abstract][Full Text] [Related]
20. Parathyroid hormone-related peptide in plasma of patients with hypercalcemia and malignant lesions.
Kao PC; Klee GG; Taylor RL; Heath H
Mayo Clin Proc; 1990 Nov; 65(11):1399-407. PubMed ID: 1700240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
